MedTrace Logo

Shorter Radiation Schedule for the Treatment of Prostate Cancer

NCT00201916 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 936

Last updated 2010-08-17

No results posted yet for this study

Summary

To improve the management of patients with early stage prostate cancer.

Conditions

Interventions

PROCEDURE

5250 cGy/20 fractions over 28 days

see above

PROCEDURE

6600 cGy/33 fractions over 45 days

see above

Sponsors & Collaborators

  • NCIC Clinical Trials Group

    collaborator NETWORK

  • Ontario Clinical Oncology Group (OCOG)

    lead OTHER

Principal Investigators

  • Himu Lukka, MD · Juravinski Cancer Centre

  • Charles Hayter, MD · Toronto Sunnybrook Regional Cancer Centre

  • Mark Levine, MD · Ontario Clinical Oncology Group (OCOG)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-03-31
Primary Completion
2008-12-31
Completion
2009-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00201916 on ClinicalTrials.gov